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Anatomical differences of women in pharmacokinetics and pharmacodynamics
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 SODVPD YROXPH LQFUHDVHG RUJDQ EORRG ÀRZ DQG DOWHUHG GUXJ  SODVPD SURWHLQ ELQGLQJ SUR¿OH LQ WKH IRUPHU >@ *HQGHU  GLIIHUHQFHV FRQFHUQLQJ SUHGLVSRVLWLRQ WR D VSHFL¿F GLVHDVH FDQ  RFFXU GXH WR WKH DFWLRQV RI VH[ VWHURLG KRUPRQHV RU LQWHUDFWLRQV  EHWZHHQ HQYLURQPHQWDO JHQHWLF DQG KRUPRQDO IDFWRUV >@  *HQGHU GLIIHUHQFHV LQÀ
7KH PHQVWUXDO F\FOH LV FKDUDFWHUL]HG E\ FKDQJHV DW WKH OHYHO RI VH[ KRUPRQHV 7KHVH FKDQJHV GLUHFWO\ DIIHFW WKH PHWDEROLVP EHFDXVH WKH\ DUH DVVRFLDWHG ZLWK WKH DFWLYDWLRQ RI VSHFL¿F KHSDWLF HQ]\PHV DQG WKH UDWH RI FOHDUDQFH RI FHUWDLQ GUXJV )RU H[DPSOH FDIIHLQH DQG WKHRSK\OOLQH FOHDUDQFH LV KLJKHU GXULQJ WKH HDUO\ IROOLFXODU SKDVH DQG SURORQJHG GXULQJ WKH PLG OXWHDO SKDVH >@ 6HYHUDO OLWHUDWXUH UHSRUWV KDYH FRQ¿UPHG WKDW KRUPRQDO ÀXFWXDWLRQV GXULQJ WKH PHQVWUXDO F\FOH LQÀXHQFH GUXJ PHWDEROLVP EXW VRPH DXWKRUV FRQFOXGHG WKDW WKHUH DUH QR GLIIHUHQFHV LQ GUXJ PHWDEROLVP ZLWK UHJDUG WR WKH PHQRSDXVDO VWDWXV DQG WKH PHQVWUXDO F\FOH > @ 'LIIHUHQFHV LQ GUXJ PHWDEROLVP DUH DOVR FDXVHG E\ KRUPRQH ÀXFWXDWLRQV GXULQJ PHQRSDXVH >@ 'DWD RQ ZKHWKHU WKH PHQRSDXVDO VWDWXV RU WKH HVWURJHQ DQG SURJHVWHURQH OHYHOV LQ +57 VLJQL¿FDQWO\ DIIHFW GUXJ PHWDEROLVP LQ ZRPHQ DUH LQFRQVLVWHQW DQG FRQÀLFWLQJ 7KH JHVWDWLRQ SHULRG LV FKDUDFWHUL]HG E\ D VHULHV RI SK\VLRORJLFDO FKDQJHV WKDW GLUHFWO\ DQG LQGLUHFWO\ DIIHFW WKH SKDUPDFRNLQHWLF SDUDPHWHUV VXFK DV DEVRUSWLRQ GLVWULEXWLRQ RU HOLPLQDWLRQ >@ &KDQJHV LQ WKH OHYHO RI SURJHVWHURQH GXULQJ SUHJQDQF\ FRQWULEXWH WR LQWHU DOLD UHGXFHG JDVWULF HPSW\LQJ VPDOO LQWHVWLQH PRWLOLW\ DQG LQFUHDVHG JDVWULF S+ 7KH HIIHFW RI WKHVH FKDQJHV FDQ EH LQFUHDVHG & PD[ DQG 7 PD[ ZKLFK LQ WXUQ FDQ OHDG WR UHGXFHG HI¿ÀXHQFH WKH LQGXFWLRQ RI VRPH HQ]\PHV RI WKH KHSDWLF F\WRFKURPH 3 V\VWHP UHVXOWLQJ LQ D KLJKHU UDWH RI GUXJ PHWDEROLVP (OLPLQDWLRQ RI GUXJV DOWHUV GXULQJ SUHJQDQF\ DV ZHOO WKH JORPHUXODU ¿OWUDWLRQ UDWH ULVHV E\ OHDGLQJ WR HQKDQFHG HOLPLQDWLRQ RI GUXJV >@ 1XPHURXV SK\VLRORJLFDO FKDQJHV RFFXU GXULQJ SUHJQDQF\ ZKLFK LQ WXUQ PD\ DIIHFW WKH SKDUPDFRNLQHWLFV RI GUXJV 7KHVH FKDQJHV FRQFHUQ ERG\ ZHLJKW DQG ERG\ IDW GHOD\HG JDVWULF HPSW\LQJ DQG SURORQJHG JDVWURLQWHVWLQDO WUDQVLW WLPH LQFUHDVHG H[WUDFHOOXODU ÀXLG DQG
Women have lower concentrations of alpha-1 acid glycoprotein than men, exogenous estrogens increase levels of the serum-binding globulins.
In women: lower levels of plasma binding proteins -lower free fraction of drugs -active form of the drug.
Metabolism Phase I
Hepatic transporters: hepatic p-gp or MDR1.
Men -higher hepatic p-gp levels than women
Higher rates of drug clearance in women versus men for drugs that are substrates of p-gp.
[26]
Basal metabolism Basal metabolism rate: man > women CYP1A1 and CYP2A1 -more active in men than women, CYP3A4 -higher activity in women
Excretion/ elimination
Renal function *ORPHUXODU ¿OWUDWLRQ SDVVLYH diffusion, active secretion: men > women
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